Fortis Healthcare Limited has completed annual interest payments totaling ₹130.47 crores to its debenture holders on December 22, 2025. The healthcare major fulfilled its regulatory obligations under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Interest Payment Details

The company made payments across three separate debenture series to institutional investors. The interest payments were distributed among major financial institutions as detailed below:

Payment Schedule and Compliance

The interest payment process followed the established timeline with specific dates for record and payment:

The payment date was adjusted from December 20 to December 22, 2025, as the original due date fell on a Saturday, which is not a business day. According to the Key Information Document provisions, when coupon payment dates fall on non-business days, interest becomes payable on the immediately succeeding business day.

Debenture Portfolio Overview

The three debenture series represent a combined principal amount of ₹1,550 crores distributed as follows:

All three series follow an annual interest payment frequency, with no changes reported in the payment structure. The company confirmed that no redemption payments were due during this period, and there were no delays or issues in the interest payment process.

Regulatory Compliance

Fortis Healthcare's timely completion of these interest payments demonstrates adherence to its debt obligations and regulatory compliance under SEBI guidelines. The company secretary and compliance officer, Satyendra Chauhan, certified the completion of all required payments to the respective debenture holders as scheduled. The certificate was filed pursuant to Regulation 57 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Fortis Healthcare has announced a significant expansion through its subsidiary, with IHL finalizing agreements to acquire TMI Healthcare and its associated hospital properties. This strategic acquisition marks an important milestone in the company's growth trajectory within the healthcare sector.

Acquisition Details

The transaction involves IHL, a subsidiary of Fortis Healthcare, completing agreements for the comprehensive acquisition of TMI Healthcare. The deal encompasses not only the healthcare operations but also includes the valuable hospital properties associated with TMI Healthcare.

Strategic Implications

This acquisition represents a strategic expansion for Fortis Healthcare, allowing the company to broaden its healthcare infrastructure and operational capabilities. The addition of TMI Healthcare's assets will contribute to strengthening Fortis Healthcare's position in the competitive healthcare market.

The inclusion of hospital properties in the acquisition provides Fortis Healthcare with valuable real estate assets alongside operational healthcare facilities. This comprehensive approach ensures that the company gains both the operational expertise and the physical infrastructure necessary for healthcare service delivery.

Corporate Development

The finalization of these agreements demonstrates Fortis Healthcare's commitment to growth through strategic acquisitions. By utilizing its subsidiary IHL for this transaction, the company has structured the acquisition to optimize operational integration and management efficiency.

This development adds to Fortis Healthcare's expanding portfolio of healthcare assets and reinforces its position as a significant player in India's healthcare industry. The successful completion of the agreement process indicates the company's ability to execute complex acquisition strategies effectively.

The acquisition of TMI Healthcare and its hospital properties by IHL marks a significant step in Fortis Healthcare's expansion strategy, further solidifying its presence in the healthcare sector and enhancing its capabilities to deliver comprehensive healthcare services.